As of September 2026 Avalo Therapeutics has a market cap of NZ$1.75 Billion. This makes Avalo Therapeutics the world's 6357th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.